Business Context and Reporting Period
Company: Nephros, Inc. (NEPH)
Filing Type: Form 8-K (Current Report)
Date of Report: April 4, 2023
Reporting Period: Preliminary results for the first quarter of 2023.
This filing serves to disclose the issuance of a press release containing preliminary financial results for Q1 2023. The detailed financial data is contained in Exhibit 99.1 (Press Release) and is furnished, not filed, for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being disclosed in the attached press release (Exhibit 99.1) but are not present in the body of this 8-K filing.
Material Changes
No specific material changes versus the prior comparable period are detailed in this text. The filing indicates that preliminary results for Q1 2023 have been issued, but does not quantify the variance from previous periods.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the release of preliminary Q1 2023 results via a press release.
Legal Status of Information: The information in this Item 2.02 and the accompanying press release is furnished and shall not be deemed "filed" under Section 18 of the Exchange Act, nor is it subject to liability under that section or incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 4, 2023) for specific Q1 2023 revenue and net loss figures.
- Verify the company's cash position and burn rate as detailed in the press release.
- Check for any updated guidance or operational milestones mentioned in the press release.
- Confirm the status of the company's securities trading on The Nasdaq Stock Market LLC under the symbol NEPH.